• Home
  • Sector News
    • Technology
    • Energy
    • Financial Services
  • Opinion and Analysis
    • Market Overview
      • Opinion
      • Technical Analysis
      • Fundamental Analysis
      • Investment Idea
    • Stock Market
      • Opinion
      • Technical Analysis
      • Fundamental Analysis
      • Stock Pick
  • Virtus Report

Subscribe to stay informed!

Discover hidden stock market gems and stay up to date with our weekly email newsletter and individual stock ideas

What's Hot

When will the stock-market pain end? Here are 3 clues investors should watch for.

September 26, 2023

Cantor Fitzgerald Maintains Soleno Therapeutics (SLNO) Overweight Recommendation

September 26, 2023

What’s In Store For CarMax In Q2 – Analyst Sees Easing Growth Comparisons, Cost Controls & More – CarMax (NYSE:KMX)

September 26, 2023
Telegram RSS
  • Government
  • Press Releases
  • Stock Market
  • Top Stories
  • Trading Insights
  • Trending
  • About Us
Telegram RSS
Virtus Junxit EquitiesVirtus Junxit Equities
  • Home
  • Sector News
    1. Technology
    2. Energy
    3. Financial Services
    4. View All

    American Society for Clinical Pathology Awarded $631,983 Grant from the CDC to Strengthen the Laboratory Workforce

    September 26, 2023

    OpenAI Discusses Share Sale: Potential $90B Valuation Signals AI Industry Growth – Microsoft (NASDAQ:MSFT)

    September 26, 2023

    Ideal World TV Channel Makes a Grand Return with an Unbeatable Selection of Lifestyle Products

    September 26, 2023

    Mount Sinai Announces New System Chief of Genomic Medicine

    September 26, 2023

    Nat-Gas Prices Decline Due to Warm U.S. Autumn Temperatures

    September 26, 2023

    Brent Crude – Oil Pares Gains in Risk-Averse Trade

    September 26, 2023

    Upwing Energy to Exhibit at SPE Gulf Coast Section Electric Submersible Pumps Symposium, Display Subsurface Compressor System™

    September 26, 2023

    Crude Prices Rise Due to Expectations of Limited Global Oil Supplies

    September 26, 2023

    Aeroflow Healthcare Celebrates Success with Ohio’s Inclusion of Diaper Tax Exemption in HB 33

    September 26, 2023

    Stocks Plunge as Confidence in the U.S. Economic Outlook Declines

    September 26, 2023

    17 Greenberg Traurig Attorneys Named 2023 LMG Life Sciences Guide ‘Life Science Stars’

    September 26, 2023

    Costco (NASDAQ:COST) Exceeds Q4 Expectations

    September 26, 2023

    When will the stock-market pain end? Here are 3 clues investors should watch for.

    September 26, 2023

    Cantor Fitzgerald Maintains Soleno Therapeutics (SLNO) Overweight Recommendation

    September 26, 2023

    What’s In Store For CarMax In Q2 – Analyst Sees Easing Growth Comparisons, Cost Controls & More – CarMax (NYSE:KMX)

    September 26, 2023

    Oppenheimer Maintains U.S. Bancorp. (USB) Outperform Recommendation

    September 26, 2023
  • Opinion and Analysis
    • Market Overview
      • Opinion
      • Technical Analysis
      • Fundamental Analysis
      • Investment Idea
    • Stock Market
      • Opinion
      • Technical Analysis
      • Fundamental Analysis
      • Stock Pick
  • Virtus Report
Get Access
Virtus Junxit EquitiesVirtus Junxit Equities
Home»Trending»Mizuho maintains Exxon Mobil (XOM) buy recommendation
Trending

Mizuho maintains Exxon Mobil (XOM) buy recommendation

James TaylorBy James TaylorSeptember 18, 2023Updated:September 18, 2023No Comments3 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr Email
Share
Facebook Twitter LinkedIn Pinterest Email

According to Fintel, Mizuho maintained its coverage of Exxon Mobil (NYSE:XOM) with a Buy recommendation on September 18, 2023.

Analyst price forecast suggests a 6.17% upside. As of August 31, 2023, the average one-year price target for Exxon Mobil is $124.90, with forecasts ranging from $101.00 to $153.30. This represents a 6.17% increase from its latest reported closing price of $117.65.

For Exxon Mobil, the projected annual revenue is $411,239MM, which is an 11.76% increase. The projected annual non-GAAP EPS is 11.46.

Exxon Mobil declared a regular quarterly dividend of $0.91 per share ($3.64 annualized) on July 28, 2023. Shareholders of record as of August 16, 2023, received the payment on September 11, 2023.

The stock’s current dividend yield is 3.09%. Looking back five years, the average dividend yield has been 5.32%, with a low of 3.08% and a high of 11.07%. The standard deviation of yields is 1.87 (n=236). The current dividend yield is 1.19 standard deviations below the historical average.

Additionally, Exxon Mobil’s dividend payout ratio is 0.28, indicating how much of the company’s income is paid out in dividends.

The company’s 3-year dividend growth rate is 0.05%, indicating an increase over time.

There are 4780 funds or institutions reporting positions in Exxon Mobil, which is a decrease of 39 owners (or 0.81%) in the last quarter. The average portfolio weight of all funds dedicated to XOM is 1.03%, a decrease of 5.27%. Total shares owned by institutions decreased by 1.66% to 2,602,083K shares in the last three months. The put/call ratio of XOM is 0.93, indicating a bullish outlook.

Shareholders such as VTSMX – Vanguard Total Stock Market Index Fund Investor Shares, VFINX – Vanguard 500 Index Fund Investor Shares, Geode Capital Management, The Energy Select Sector SPDR Fund (XLE), and Bank Of America are actively involved in holding shares of Exxon Mobil.

ExxonMobil is one of the largest publicly traded international energy companies. It holds an industry-leading inventory of resources and is one of the largest refiners and marketers of petroleum products, with a chemical company that is one of the largest in the world.

Fintel provides comprehensive investing research platforms with data covering fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and more. They also offer exclusive stock picks powered by advanced, backtested quantitative models for improved profits.

For more information, click here.

This story originally appeared on Fintel.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Previous ArticleMizuho Maintains Marathon Oil (MRO) Neutral Recommendation
Next Article Appeal of Conscience Foundation Honors Dr. Henry Kissinger with the 2023 World Statesman Award at the 58th Annual Gala
James Taylor
  • Website
  • X (Twitter)

A writer and finance enthusiast who loves diving into the exciting world of stocks, commodities, forex, and crypto. I'm all about making the financial markets less intimidating and more accessible, so I write engaging content that simplifies complex concepts and shares practical investment strategies. Whether you're a seasoned investor or just getting started, I've got your back! But hey, life isn't all about work, right? On weekends, you'll find me hanging out and having a blast with my awesome friends and family. We love bonding over shared interests, trying out new adventures, and simply enjoying each other's company. Striking that balance between work and play is super important to me, because what's the point of success if you can't share it with the people you love? So, if you're up for some financial market insights and a good dose of weekend fun, stick around! Together, we'll navigate the money world and make the most of our time off. Let's learn, grow, and create memories along the way!

Related Posts

Cantor Fitzgerald Maintains Soleno Therapeutics (SLNO) Overweight Recommendation

September 26, 2023By James Taylor0

If You Invested $2,000 in PubMatic in 2020, This Is How Much You Would Have Today

September 26, 2023By James Taylor0

VIS Makes Notable Cross Below Critical Moving Average

September 26, 2023By James Taylor0

Leave A Reply Cancel Reply

Our Picks
Technology

American Society for Clinical Pathology Awarded $631,983 Grant from the CDC to Strengthen the Laboratory Workforce

By James TaylorSeptember 26, 2023
Financial Services

Aeroflow Healthcare Celebrates Success with Ohio’s Inclusion of Diaper Tax Exemption in HB 33

By James TaylorSeptember 26, 2023
Technology

OpenAI Discusses Share Sale: Potential $90B Valuation Signals AI Industry Growth – Microsoft (NASDAQ:MSFT)

By James TaylorSeptember 26, 2023
Financial Services

Stocks Plunge as Confidence in the U.S. Economic Outlook Declines

By James TaylorSeptember 26, 2023
Stay In Touch
  • Facebook
  • Twitter
  • Pinterest
  • Instagram
  • YouTube
  • Vimeo
Don't Miss
Trending

Cantor Fitzgerald Maintains Soleno Therapeutics (SLNO) Overweight Recommendation

By James TaylorSeptember 26, 2023

Cantor Fitzgerald has maintained its coverage of Soleno Therapeutics (NASDAQ: SLNO) with an Overweight recommendation, according to Fintel. Analysts forecast a 183.97% upside for Soleno Therapeutics, with an average one-year price target of 12.58. The price targets range from a low of 8.08 to a high of $19.95. This represents…

What’s In Store For CarMax In Q2 – Analyst Sees Easing Growth Comparisons, Cost Controls & More – CarMax (NYSE:KMX)

September 26, 2023

Oppenheimer Maintains U.S. Bancorp. (USB) Outperform Recommendation

September 26, 2023

If You Invested $2,000 in PubMatic in 2020, This Is How Much You Would Have Today

September 26, 2023
FEATURED INSIGHTS​
Top Stories

When will the stock-market pain end? Here are 3 clues investors should watch for.

By James TaylorSeptember 26, 2023
Trending

Cantor Fitzgerald Maintains Soleno Therapeutics (SLNO) Overweight Recommendation

By James TaylorSeptember 26, 2023
Trading Insights

What’s In Store For CarMax In Q2 – Analyst Sees Easing Growth Comparisons, Cost Controls & More – CarMax (NYSE:KMX)

By James TaylorSeptember 26, 2023

Subscribe to stay informed!

Discover hidden stock market gems and stay up to date with our weekly email newsletter and individual stock ideas

Telegram RSS
  • Home
  • Privacy Policy
  • Disclaimer
  • Virtus Report
  • Get Access
  • About Us
© 2023 Virtus Junxit LLC

Type above and press Enter to search. Press Esc to cancel.